From GWAS to EWAS: Chirag Patel and and Gary Miller on the Rise of Exposomics

Agilent Partners with PacBio to Speed Adoption of Long Reads into Diagnostic Testing

How AI Is Doing Science with Vivek Adarsh, CEO of Mithrl

Inventor Mark Kokoris on Roche’s New Sequencing by Expansion

From Brewing Sake to Brewing Science: Takara Bio’s Bold New Chapter with CSO Andrew Farmer

How Pathologists Can Lead in Precision Medicine with David Braxton

From DNA to Proteins: Illumina Makes Its Proteomics Play - with Krishna Morampudi

Theranos Had the Vision. Truvian Has the Execution. Our Chat with CEO Jay Srinivasan

Physicians Don't Want a Laundry List of Genes says Premal Shah, CEO of Myome

The Customer Case for iconPCR with Stefan Green and Yann Jouvenot

Alex Dickinson on Long Read Sequencing, Multi Omics, and the Next Frontier in Genomics

Rapid Answers for Rare Disease: Katherine Stueland on GeneDx’s Mission

Moran Snir's Vision for Making Genomic Care Routine across the U.S.

How Certis Is Rewriting Cancer Models with CEO Peter Ellman

Myriad’s Next Chapter: New CEO Sam Raha on Growth, AI, and MRD Testing

Next-Gen MRD Testing: Foresight’s Leap in Sensitivity with Jake Chabon and Dave Kurtz

Bodour Salhia and Danielle Goldberg: Rethinking Cancer Research with Illumina's 5-Base Solution

Reinventing PCR: Pranav Patel, N6 Tec

Making Whole Genome Sequencing the Universal Genetic Test - with David Ledbetter, Pediatric Rare Disease Institute, FSU

Remembering Atul Butte with Marina Sirota, Chirag Patel and Mike Snyder